Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT01747629
- Locations
- 🇺🇸
Teva Investigational Site 10239, Tallahassee, Florida, United States
🇺🇸Teva Investigational Site 10228, Spartanburg, South Carolina, United States
🇺🇸Teva Investigational Site 10225, Costa Mesa, California, United States
Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
- First Posted Date
- 2012-11-07
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT01723228
- Locations
- 🇺🇸
Teva Investigational Site 003, Chicago, Illinois, United States
🇺🇸Teva Investigational Site 016, La Jolla, California, United States
🇺🇸Teva Investigational Site 004, Irvine, California, United States
The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
- First Posted Date
- 2012-10-16
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 2199
- Registration Number
- NCT01707992
- Locations
- 🇺🇸
Teva Investigational Site 10315, Sunrise, Florida, United States
🇺🇸Teva Investigational Site 10342, Tucson, Arizona, United States
🇺🇸Teva Investigational Site 10341, Saint Petersburg, Florida, United States
Safety Study of Albuterol Spiromax® in Subjects With Asthma
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 364
- Registration Number
- NCT01698320
- Locations
- 🇺🇸
Teva Investigational Site 10146, Bellevue, Nebraska, United States
🇺🇸Teva Investigational Site 10154, Gainesville, Georgia, United States
🇺🇸Teva Investigational Site 10143, Cincinnati, Ohio, United States
Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT01697956
- Locations
- 🇺🇸
Teva Investigational Site 10305, Long Beach, California, United States
🇺🇸Teva Investigational Site 10304, Stockbridge, Georgia, United States
🇺🇸Teva Investigational Site 10302, Normal, Pennsylvania, United States
Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
- Conditions
- Perennial Allergic Rhinitis (PAR)
- Interventions
- Drug: Beclomethasone Dipropionate (BDP) Nasal Aerosol
- First Posted Date
- 2012-07-03
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 824
- Registration Number
- NCT01632540
- Locations
- 🇺🇸
Teva Investigational Site 024, Little Rock, Alaska, United States
🇺🇸Teva Investigational Site 010, Tamarac, Florida, United States
🇺🇸Teva Investigational Site 033, Mandeville, Louisiana, United States
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01624480
- Locations
- 🇺🇸
Teva Investigational Site 23, Raleigh, North Carolina, United States
🇺🇸Teva Investigational Site 1, Atlanta, Georgia, United States
🇺🇸Teva Investigational Site 7, Little Rock, Arkansas, United States
A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment
- First Posted Date
- 2012-05-11
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01596621
- Locations
- 🇨🇳
Teva Investigational Site 025, Hefei, China
🇨🇳Teva Investigational Site 005, Shanghai, China
🇨🇳Teva Investigational Site 009, Shenyang, China
Adenovirus Vaccine Pregnancy Registry
- Conditions
- Adenovirus
- First Posted Date
- 2012-04-24
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Registration Number
- NCT01584037
- Locations
- 🇺🇸
INC Research, LLC (Registry Coordinating Center), Wilmington, North Carolina, United States
An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
- Conditions
- Relapsing-Remitting Multiple Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-04-17
- Last Posted Date
- 2014-04-02
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 178
- Registration Number
- NCT01578785
- Locations
- 🇺🇸
Teva Investigational Site 10212, Raleigh, North Carolina, United States
🇧🇾Teva Investigational Site 68004, Grodno, Belarus
🇧🇬Teva Investigational Site 59027, Veliko Tarnovo, Bulgaria